Boehringer Ingelheim voluntarily withdraws Silomat worldwide

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1168卷 / 1期

关键词：

Public Health; Adverse Effect; Healthy Subject; Potential Risk; Healthcare Provider;

D O I：

10.2165/00128415-200711680-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] Boehringer Ingelheim withdraws libido drug for women
Lenzer, Jeanne
[J]. BRITISH MEDICAL JOURNAL, 2010, 341
[2] Boehringer Ingelheim
不详
[J]. VETERINARY RECORD, 2019, 185 (10) : 289 - 289
[3] Merck voluntarily withdraws Vioxx worldwide due to CV risk
[J]. Reactions Weekly, 2004, 1022 (1) : 2 - 2
[4] Boehringer Ingelheim GmbH
不详
[J]. BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1999, 12 (12): : 24 - 24
[5] JOBS AXED AT BOEHRINGER INGELHEIM
Mullin, Rick
[J]. CHEMICAL & ENGINEERING NEWS, 2013, 91 (34) : 17 - 17
[6] BOEHRINGER INGELHEIM CELEBRATES CENTENARY
WOODS, D
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1985, 132 (12) : 1417 - &
[7] Boehringer Ingelheim will acquire Actimis
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2008, 86 (25) : 18 - 18
[8] BOEHRINGER INGELHEIM ACQUIRES AND DIVESTS
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2011, 89 (04) : 19 - 19
[9] SAPC/Boehringer Ingelheim Awards
Beytell, Elaine
du Preez, Alet
[J]. SA PHARMACEUTICAL JOURNAL, 2009, 76 (01) : 55 - 55
[10] Merial to merge with Boehringer Ingelheim
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2016, 249 (04): : 370 - 370

← 1 2 3 4 5 →